Clinical efficacy between cefoperazone-sulbactam and prolonged infusion of piperacillin-tazobactam in the treatment of severe CAP, HAP and VAP: a retrospective multicenter cohort study

C. Sun (Taipei, Taiwan), W. Chen (Taipei, Taiwan)

Source: International Congress 2022 – Pneumonia

Session: Pneumonia
Session type: Oral Presentation
Number: 4405

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Sun (Taipei, Taiwan), W. Chen (Taipei, Taiwan). Clinical efficacy between cefoperazone-sulbactam and prolonged infusion of piperacillin-tazobactam in the treatment of severe CAP, HAP and VAP: a retrospective multicenter cohort study. 4405

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.